I went to an endocronologist for osteoperosis. He took tests and one of them was the protein test. It showed that I had an IGM of 500. I had no idea what IGM was, I was then sent to a hemotologist, oncologist and had.a 24 hour urine test, negative, bone survey , negative and the bone marrow aspiration and biopsy. After a three week wait, he said I had Smoldering Waldentroms. He didn't make much of it. He said I will be watched withut treatment. I have no symptoms. In 4 months, I will have a blood test. This is a new one for me. If I didn't go to the endocronologist, I would never know anything was wrong. If anyone else has been diagnosed with Smoldering Waldenstroms, please let me know what you know about it.---Arls516
"TI Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
AU Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
SO Semin Oncol 2003 Apr;30(2):231-5.
Factors predicting evolution to symptomatic disease were investigated in 27 patients with smouldering Waldenstrom's macroglobulinemia (SWM) among 172 patients with Waldenstom's macroglobulinemia (WM), selected on the basis of the following criteria: (1) IgM paraprotein > 3 g/dL, and/or (2) bone marrow (BM) lymphoplasmacytoid (LPC) infiltration >or= 30%, and/or (3) diffuse infiltration pattern on BM biopsy, and (4) no treatment requirement for at least 12 months. Cumulative probability of survival was calculated by means of Kaplan-Meier. The Mantel and Haenszel test and multivariate Cox model were used to identify possible predictors for evolution. At a median follow-up of 79 months (range, 14 to 204), 11 patients (40.7%) showed progression to symptomatic disease, with the median interval from diagnosis being 46 months (range, 12 to 154). Event-free survival (EFS) at 5 and 10 years was 65% (95% confidence interval [CI], 45% to 85%) and 53% (95% CI, 31% to 75%), respectively. At multivariate analysis, paraprotein > 3 g/dL (hazard ratio [HR], 15.1; 95% CI, 3.01 to 75.64; P <.0009) and hemoglobin <or= 12.5 g/dL (HR, 3.75; 95% CI, 1.05 to 13.34; P <.042) independently predicted transformation into symptomatic disease (P 3 g/dL and hemoglobin levels <or= 12.5 gr/dL are likely to predict SWM transformation into active disease requiring treatment.
AD Department of Hematology, Bone Marrow Transplantation Centre, Niguarda Ca' Granda Hospital, Milan, Italy.
I would like to point out that this article was published six years ago so the thinking on whether to intervene during the "smoldering" stage may have changed. In multiple myeloma I believe that sometimes they DO intervene during this stage based on certain factors. I would probably get a second opinion from someone at Dana Farber or MD Anderson, where they see plenty of Waldenstrom's patients.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.